Journals / Selçuk Tıp Dergisi / 2009 / Cilt: 25 - Sayı: 4

Electromyography results of amyloidosis related with dialysis in high flux and standart hemodialysis

High flux ve standart hemodiyalizde diyaliz ilişkili amiloidozisde elektromyografi bulguları

Pages
182–185
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The initiation of HF TD appears to be reasonable before the findings of amyloidosis related with dialysis was started in susceptible cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study was undertaken to evaluate the electromyograpy (emg) and laboratory findings of amyloidosis related with dialysis in the patients treated with high flux (HF) and standart (STD) hemodialysis (HD).
📊
Key Findings & Data:Method: This study included a total of 16 standart HD and 16 HF HD patients who were treated with dialysis for at least 3 years.
💡
Conclusion & Impact:The initiation of HF TD appears to be reasonable before the findings of amyloidosis related with dialysis was started in susceptible cases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: This study was undertaken to evaluate the electromyograpy (emg) and laboratory findings of amyloidosis related with dialysis in the patients treated with high flux (HF) and standart (STD) hemodialysis (HD). Method: This study included a total of 16 standart HD and 16 HF HD patients who were treated with dialysis for at least 3 years. Median nevre (motor and sensory), Unlar nevre (motor and sensory), Fibular motor, Posterior Tibial motor and Sural sensorial nerves were evaluated. Blood β2 mikroglobulin levels in these patients were investigated. Results: There was statistical significant difference in regard to blood β2 mikroglobulin levels between both groups (p=0.00). EMG findings of Carpal tunel syndrome (CTS) was observed in 20% and 25% of the patients treated with ST HD and HF HD (respectively). There was no statistical significant difference in terms of EMG findings between two groups (p=0.539). Conclusion: EMG is a useful method in the detection of neurological findings such as CTS. The initiation of HF TD appears to be reasonable before the findings of amyloidosis related with dialysis was started in susceptible cases.

Özet

Amaç: High Flux (HF) ve standart (STD) hemodiyaliz (HD) uygulanan hastalarda diyaliz ilişkili amiloidozisin (DİA) elektromyografi (EMG) ve laboratuar bulgularının değerlendirilmesi. Yöntem: En az 3 yıldır diyalize giren 16 standart HD ve 16 HF HD hastası çalışmaya alındı. Sinir iletim çalışmalarında elektromyografik inceleme ile, median (motor ve duysal) ve Ulnar (motor ve duysal) sinir, Fibuler motor, Posterior tibial motor ve Sural duysal sinirlere bakıldı. Hastalarda serum β2 mikroglobulin düzeyleri araştırıldı. Bulgular: İki grup arasında serum β2 mikroglobulin düzeyleri arasında fark mevcuttu ( p= 0.00 ). STD HD alan olguların % 20’sinde, HF HD alan olguların % 25’inde karpal tünel sendromu (KTS)’ nun EMG bulguları mevcuttu. İki grup açısında EMG bulguları açısından istatistiksel olarak anlamlı bir fark saptanmadı (p=0,539). Sonuç: DİA karpal tünel sendromu gibi nörolojik bulgularının saptanmasında EMG yararlı bir yöntemdir. Riskli olgularda diyaliz ilişkili amiloidozis bulguları başlamadan HF HD tedavisine geçilmesi akılcı yaklaşım olacaktır.

🔖

Cite This Article

ÇELİK, G., BADEMKIRAN, F. (2009). Electromyography results of amyloidosis related with dialysis in high flux and standart hemodialysis. Selçuk Tıp Dergisi, Cilt: 25 - Sayı: 4, 182–185. https://ajindex.com/articles/319294

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Kock KM. Dialysis-related amyloidosis. Kidney İnt 1992
  2. 1429 2. Spragua SM, popovtzer MM. Is β2-microglobulin a mediator of bone disease? Kidney İnt 1995
  3. 6 3. Laurent G, Calemard E, Charra B: Dialysis related amiloidosis. Kidney Int Suppl 1988
  4. S32 4. Mauri CPJ: Beta-2 microglobulin amyloidosis. Rheumatol Int 1990
  5. 1 5. Ferreira A, Urena P, Ang KS, Simon P, Morieux C, Souberbielle JC, de Vernejoul MC, Drüeke TB. Relationship between serum β2-microglobulin, bone histology, and dialysis membranes in uraemic patients. Nephrol Dial Transplant 1995
  6. 1707 6. Balint E, Marshall CF, Sprague SM. Role of İL-6 in β2-microglobulin- induced bone mineral dissolition. Kidney Int 2000
  7. 1607 7. Dinarello C: Citokines: Agents provocateurs in hemodialysis? Kidney Int 1992
  8. 694 8. Van Ypersele de Strihou C,Jadoul M, Malghem J, Maldegue B. Effect of dialis membrane and patient’s age on signs of dialysis-related amiloidosis. Kidney Int 1991
  9. 1019 9. Jaudul M. Dialysis related amiloidosis: importance of biocompatibility and age. Nephrol Dial Transplant 1998
  10. 13(suppl 7: 61-64) 10. Ahn SY, Hong YH, Koh YH, Chung YS, Lee SH, Yang HJ. Pressure measurement in carpal tunnel syndrome: correlation with electrodiagnostic and ultrasonographic findings. J Korean Neurosurg Soc. 2009 Sep
  11. 46(3):199-204 11. Kleinman KS, Coburn JW: Amyloid Syndromes associated with hemodialysis. Kidney Int.1989
  12. 567 12. Gejyo F, Homma N, Arakawa M. Long term complication of dialysis. Pathologic factors with special referance to amyloidosis. Kidney Int 1993
  13. 43(Suppl 41):S78-S 82 13. Zingraff J, Noel LH, BardinT. β2-microglobulin Amyloidosis as a complication of chronic renal faillure. N Eng J Med 1990
  14. 1071 14. Koda Y, Nishi S, Miyazaki S et al: Switch from conventionel tohigh-flux membrane reduces the risk of carpal tunnel syndroma and mortality of hemodialysis patients.Kiney Int 1997
  15. 1101 15. Mrowka CH, Schıffl H. Comparative evaluation of B2-microglobulin removal by different hemodialysis membranes: A six years follow-up. Nephron 1993
  16. 369 16. Locatelly F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, Italian Cooperative Dialysis study Group: Effects of different membranes and dialysis tecnologies on patient treatment tolerance and nutritional parameters. Kidney Int 1996
  17. 1302 17. Koda Y, Suziki M, Hirasawa Y. Efficacy of choice of dialysis mebrane. Nephrol Dial Transplant 2001
  18. 16(suppl 4): 23-26 18. Kuchle C,